Experts have asserted that “the consumer is ready” for biotics delivering targeted benefits as opposed to general microbiome support, amid a rising demand for psychobiotics and an increasing awareness of the gut-brain axis.
A blend of four probiotic strains may lead to “widespread improvements” in measures of mood, anxiety, and depression in healthy young men and women, says a new study using Probiotical’s multi-strain probiotic, Bifizen.
As consumers get more comfortable with probiotics for gut health, “probiotics plus” is emerging as a key motif. The idea of probiotics for mood support, or psychobiotics, is picking up steam as growing research shows the digestive aids hold promise for...
Novozymes OneHealth, supplier of probiotics, enzymes, and bioactive ingredients, exhibited its ‘ProbioBrain’ psychobiotic containing the targeted Bifidobacterium Longum 1714 strain, at Vitafoods last week.
The gut-brain axis is a hot topic amongst scientists, doctors, and dietary supplement businesses today, but this was not the case just five years ago, where the idea of using probiotics to address mental and cognitive health issues was met with much scepticism.
Taiwan's Bened Biomedical is expanding its psychobiotic business from APAC to Europe, with a new proprietary probiotic strain, as well as recent research on its established PS128 product, driving the firm's continued growth.